Cascade Biocatalysts: Funding, Investors & Team (Oct 2026)
Cascade Biocatalysts is developing more efficient enzymes to produce sustainable chemicals in a cost-effective manner. The company tackles the increasing demand for durable and reliable biocatalysts through their enzyme immobilization platform, which is protected under a patent. By combining enzymes with advanced materials, Cascade is able to create a superior product. We invite you to join us in contributing to the growth of the bioeconomy.
Cascade Biocatalysts has raised $2.6M across 1 funding round on record, the most recent a Pre-Seed of $2.6M announced in Aug 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cascade Biocatalysts Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Cascade Biocatalysts Funding Rounds
Cascade Biocatalysts Founders and Leadership Team
Contact details for the Cascade Biocatalysts team: 1 of 1 has an email address on file.
Start 14-day free trial →Cascade Biocatalysts Funding Compared to Other Biotechnology Startups
Cascade Biocatalysts' latest round of $2.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cascade Biocatalysts in Biotechnology and Denver
Companies Similar to Cascade Biocatalysts
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Cascade Biocatalysts Funding FAQs
What does Cascade Biocatalysts do?
Cascade Biocatalysts is developing more efficient enzymes to produce sustainable chemicals in a cost-effective manner. The company tackles the increasing demand for durable and reliable biocatalysts through their enzyme immobilization platform, which is protected under a patent. By combining enzymes with advanced materials, Cascade is able to create a superior product. We invite you to join us in contributing to the growth of the bioeconomy.
How much funding has Cascade Biocatalysts raised?
Cascade Biocatalysts has raised $2.6M across 1 round on record. The most recent is a Pre-Seed of $2.6M announced in Aug 2023.
When did Cascade Biocatalysts last raise funding?
Cascade Biocatalysts' most recent funding round on record is a Pre-Seed of $2.6M, announced in Aug 2023.
Who founded Cascade Biocatalysts?
FundedIQ lists James Weltz (Founder) at Cascade Biocatalysts.
Where is Cascade Biocatalysts headquartered?
Cascade Biocatalysts is based in Denver, Colorado, United States.
How many employees does Cascade Biocatalysts have?
Cascade Biocatalysts is in the 1-10 employee band.
How does Cascade Biocatalysts' funding compare to other Biotechnology startups?
Cascade Biocatalysts' latest round of $2.6M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cascade Biocatalysts Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cascade Biocatalysts is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.